scispace - formally typeset
W

Won Ho Kim

Researcher at Yonsei University

Publications -  748
Citations -  21405

Won Ho Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Inflammatory bowel disease & Colorectal cancer. The author has an hindex of 61, co-authored 704 publications receiving 18779 citations. Previous affiliations of Won Ho Kim include KAIST & Seoul National University.

Papers
More filters
Journal ArticleDOI

IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor.

TL;DR: In this article, the authors investigated the CSC-promoting effect of factors released from myofibroblasts into the microenvironment of early colorectal cancer tumors and its molecular mechanism.
Journal ArticleDOI

Characterization of AN-SBR/Silica Compound with Acrylonitrile as a Polar Group in SBR

TL;DR: In this paper, an acrylonitrile-styrene-butadiene rubber (AN-SBR) was applied to a silica compound to examine the various properties that are required for tire tread compound.
Journal ArticleDOI

Shielded laser ablation icp-ms system for the characterization of high burnup fuel

TL;DR: In this article, a radiation shielded laser ablation ICP-MS system was installed and a performance test of the developed system was conducted to evaluate the safe operation of instruments, and a solid sampling in the micro meter region was needed so that the distribution of isotopes can be determined.
Journal ArticleDOI

Early Versus Late Surgery in Patients With Intestinal Behçet Disease

TL;DR: According to the current study, the patients with intestinal Behçet disease undergoing early surgery showed better prognoses in comparison with those undergoing late surgery, and early surgery may represent a valid approach in the initial management of the patients, at least in the subset of the Patients with acute symptoms.
Journal ArticleDOI

Colon cancer surveillance

TL;DR: It is shown that cancer surveillance can lead to an improved outcome in patients who go on to develop cancer, and further studies examining the potential impact of a similar program in Crohn's disease should be considered.